How to use the speech recognition tool?
Interventional Study of Implantation of hESC-derived RPE in Patients With RP Due to Monogenic Mutation.
Status of the trial: Active, Recruiting
Orphan Drug Recognition: NA
- Opening Date: 2019-08-19
- Closing Date: 2026-12-15
Funder Type: other
HCP: Principal investigators
HCP: Other investigators
Within ERN-EYE members
- Retinal Rare Eye Diseases (WG1)
This ERN is supported by: